<DOC>
	<DOCNO>NCT02863900</DOCNO>
	<brief_summary>The main objective project characterize deregulation CE ( Cholesterol Epoxides ) metabolism different moleculars subtypes BC ( BC=Breast Cancer ) ( luminal A B , HER2+ triple negative ) . We study level expression enzyme involve pathway immuno-histochemistry , enzymes involve identified preclinical work ( GSTA1 ( Glutathione S-Transferase A1 ) , DHCR7 , D8D7I , 11βHSD2 ( 11β-hydroxysteroid dehydrogenase type 2 ) ) , also metabolite rate CE ( hydrolyse cholesterols-5,6-epoxide ) , CT ( cholestane-3β , 5α , 6β triol ) , DDA ( Dendrogenin A ) OCDO ( 6-oxo-cholestan-3β , 5α-diol ) . Our preliminary result demonstrate feasibility dosage . We also establish whether deregulation ) correlate different histo-prognostic parameter ( pN ( N= Node ) , pT ( T= Tumor ) , EV , TIL… ) also clinical ii ) independent prognostic parameter BC term disease-free survival , metastasis-free survival overall survival . The cohort consist 350 case BC , treat 2009 2011 well relevant clinical information . In parallel , continue preclinical work characterize target mechanisms action OCDO . Our preliminary result indicate OCDO modulator glucocorticoid receptor ( GR ) , could target inhibit pathway . On hand , characterize manner human tumor , deregulation CE metabolism vitro vivo ( include xenograft mice human tumor , collaboration Roman-Roman S ) representative panel BC molecular subtypes , sensitive usually administer clinical treatment study anti-tumor effect various `` anti-OCDO '' therapy ( therapy prevent production Tam ( tamoxifen ) DDA , inhibitor enzyme produce OCDO , inhibitor GR ( glucocorticoid receptor ) ) , alone combination conventional therapy</brief_summary>
	<brief_title>From Characterization Cholesterol-epoxide Pathway Deregulation New Therapeutic Perspectives Breast Cancers</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Age &gt; 18 year old Affiliated French social security system . Subjects must provide write informed consent prior studyspecific procedure assessment Pregnant breastfeed woman Subject law protect Any serious and/or unstable preexist psychiatric , familial , geographic social condition could interfere medical followup compliance study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>